CAV1 and cancer: Alternatively, EGF treatment induces caveola-dependent endocytosis of plasma membrane E-cadherin/β-catenin complex, disrupts cell–cell contacts, downregulates E-cadherin as well as CAV1, and thereby promotes invasion of cancer cells [99].